WHO WE ARE
Astron Medtech is committed to developing new orthopedic soft tissue repair medical devices. Our dynamic team includes orthopedic surgeons, medical engineers, and experienced marketing experts.
Meet Astron MedTech
Ben Huang
MS, College of Medicine, NTU UCSD Visiting Scholar
I-Lin Tsai
Co-Founder & COO
MS, College of Medicine, NTU
Steven Chen
CTO
20 years of Product Design experience
Chen-Chie Wang, MD, PhD
Foot, Ankle Orthopedic Surgeon
Director of Tissue Engineering Stem Cell Center, Taipei Tzu Chi Hospital
Chung-Li Wang, MD.PhD
KOL, Advisor
Foot, Ankle Orthopedic Surgeon
Professor, NTUH
Director of NTUH Yunlin Branch
Our Advisors
Partner with renowned surgeons and leading experts to develop cutting-edge solutions for orthopedic soft tissue repair.
Our Milestones
2024
2023
2022
2021
First in Human
FDA Clearance Obtained
Seed Round Completed
Medtech Innovator APAC
MassChallenge 2022 B2MC Cohort
SelectUSA Medtech World Championship
UC Berkeley SPH Program
FITI National Winner
SNQ Award
In the United States
We have begun to establish ourselves in the US market, collaborating with the UC Berkeley School of Public Health.
In 2022, Astron won the top prize of the 2022 SelectUSA Investment Summit in the MedTech categories against 16 other finalists. In 2024, Astron Medtech received FDA clearance and completed the First In Human.
In Taiwan
We have a strong collaboration with Tzu Chi Hospital where the technology has been implemented in 150+ clinical cases. We received the SNQ award in 2021.
